South Korea-based pharmaceutical company Boryung Pharmaceutical has put KRW1bn ($840,000) into a digital healthcare fund called Boryung D:HealthCovery, Korea Biomedical Review reported yesterday.
Boryung will invest in and help develop digital health startups through the scheme, which will collaborate with accelerator Invention Lab. Portfolio companies will also be able to collaborate with affiliates of the corporate.
The moves comes after Boryung committed about $2m to a corporate venturing programme for its US subsidiary, Hayan Health Network, last month.
